SYNCOM FORMULATIONS (INDIA)
Back to All Ratios
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 0.88 | 0.58 | 0.32 | 0.26 | 0.28 |
What is the latest Cash Earnings per Share (CEPS) ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2026 | 0.88 |
| Mar2025 | 0.58 |
| Mar2024 | 0.32 |
| Mar2023 | 0.26 |
| Mar2022 | 0.28 |
How is Cash Earnings per Share (CEPS) of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2026 | 0.88 | 51.72 | |
| Mar2025 | 0.58 | 81.25 | |
| Mar2024 | 0.32 | 23.08 | |
| Mar2023 | 0.26 | -7.14 | |
| Mar2022 | 0.28 | - | |
Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹2,074.6 Cr | -1.8% | 10.2% | 30.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,831.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,074.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,355.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹107,439.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,417.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -1.8% |
10.2% |
30.5% |
| SENSEX | 0.9% |
-0.8% |
-10.5% |
You may also like the below Video Courses